These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 22270509)
1. Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer. Oh JR; Seo JH; Chong A; Min JJ; Song HC; Kim YC; Bom HS Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):925-35. PubMed ID: 22270509 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer. Zhu D; Ma T; Niu Z; Zheng J; Han A; Zhao S; Yu J Lung Cancer; 2011 Sep; 73(3):332-7. PubMed ID: 21292341 [TBL] [Abstract][Full Text] [Related]
6. High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer. Lee YJ; Cho A; Cho BC; Yun M; Kim SK; Chang J; Moon JW; Park IK; Choi HJ; Kim JH Clin Cancer Res; 2009 Apr; 15(7):2426-32. PubMed ID: 19318478 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Chen HH; Chiu NT; Su WC; Guo HR; Lee BF Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer]. Ding CY; Guo Z; Li YY; Li TR Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):828-834. PubMed ID: 29151289 [No Abstract] [Full Text] [Related]
9. Prognostic value of Choi EK; Park M; Im JJ; Chung YA; Oh JK J Int Med Res; 2020 Apr; 48(4):300060519892419. PubMed ID: 31880209 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma. Kim CY; Hong CM; Kim DH; Son SH; Jeong SY; Lee SW; Lee J; Ahn BC Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1321-9. PubMed ID: 23674211 [TBL] [Abstract][Full Text] [Related]
11. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer. Kim CY; Jeong SY; Chong GO; Son SH; Jung JH; Kim DH; Lee SW; Ahn BC; Lee J Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of standardised uptake value (SUV Yilmaz Demirci N; Yilmaz Ü; Biner Uslu I; Dikmen A; Yılmaz A; Erdoğan Y Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26988938 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer. Arslan N; Tuncel M; Kuzhan O; Alagoz E; Budakoglu B; Ozet A; Ozguven MA Ann Nucl Med; 2011 Jul; 25(6):406-13. PubMed ID: 21409347 [TBL] [Abstract][Full Text] [Related]
14. Incorporation of circulating tumor cells and whole-body metabolic tumor volume of Fu L; Zhu Y; Jing W; Guo D; Kong L; Yu J Chin J Cancer Res; 2018 Dec; 30(6):596-604. PubMed ID: 30700928 [TBL] [Abstract][Full Text] [Related]
15. Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer. Oh JR; Seo JH; Hong CM; Jeong SY; Lee SW; Lee J; Min JJ; Song HC; Bom HS; Kim YC; Ahn BC Lung Cancer; 2013 Aug; 81(2):218-25. PubMed ID: 23731740 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer. Zhang H; Wroblewski K; Pu Y Acta Radiol; 2012 Jun; 53(5):561-8. PubMed ID: 22661603 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Lee JW; Choi JS; Lyu J; Lee SM Lung Cancer; 2018 Apr; 118():41-47. PubMed ID: 29572001 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer. Araz M; Soydal C; Özkan E; Sen E; Nak D; Kucuk ON; Gönüllü U; Kir KM Q J Nucl Med Mol Imaging; 2022 Mar; 66(1):61-66. PubMed ID: 31271268 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of volumetric metabolic parameters measured by [18F]fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer. Park SB; Choi JY; Moon SH; Yoo J; Kim H; Ahn YC; Ahn MJ; Park K; Kim BT Cancer Imaging; 2014 Apr; 14(1):2. PubMed ID: 25609313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]